$33.380
-1.472 (-4.41%)Zum Schluss
KN-News
KN-Events
Knowles Projects FY26 Revenue at $689M
Knowles sees FY26 revenue $689M, consensus $666.6M
Sees Q4 Revenue of $180M-$190M
Sees Q4 revenue $180M-$190M, consensus $174.6M
Company Reports Q3 Revenue of $184.0M, Beating Expectations
Reports Q3 revenue $184.0M, consensus $172.1M. "Total Company revenue grew 20% year over year in the third quarter, and our book-to-bill ratio in Precision Devices remained above one for the eighth consecutive quarter, reflecting continued order strength," CEO Jeffrey Niew said. "By executing our strategy-leveraging our differentiated technologies, developing custom products through close customer collaboration, and scaling production with our world-class operational capabilities-we delivered strong growth across the four major markets we serve: Medtech, Defense, Industrial, and Electrification. Additionally, at the mid-point of our fourth quarter guided range, full year 2026 revenue is expected to grow 16%. I am pleased with the Company's performance and excited about the opportunities ahead."
Knowles Partners with Elucent Medical to Produce Smart Surgical Guidance Device
Knowles announced an agreement to produce Elucent Medical's smart surgical guidance device for use with its EnVisio In-Body Spatial IntelligenceTM System. Leveraging Knowles' micro molding capabilities and using a design-for-manufacturability, or DFM, optimization approach, Knowles worked with Elucent to iterate designs, identify tolerance and material improvement opportunities, and provide guidance throughout product design, development, and launch of their surgical guidance device.
Sees Q3 Revenue of $167M-$177M
Sees Q3 revenue $167M-$177M, consensus $163.45M.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.